Forward Looking Statements & Non-IFRS Measures This presentation and the oral statements made during this meeting contain certain statements that constitute forward-looking information within the meaning of applicable securities laws ("forward-looking statements"). Such forward-looking statements in
Slide 3: Quarterly Highlights
Quarterly Highlights ▪ Strong business performance despite Covid-19 challenges ▪ Record Order Bookings (up 18% y/y) & healthy Order Backlog provide good revenue visibility ▪ Revenues up 1% y/y (10% sequentially) driven by Services, strong showing from Life Science, Consumer Products, and Energy vert
Cash Flow Generation Cash Flow from Operations2 Free Cash Flow1,2 $146 $128 $79 $72 $11 -$7 Q3-F20 Q3-F21 YTD-F20 YTD-F21 -$23 -$28 Q3-F20 Q3-F21 YTD-F20 YTD-F21 Net Debt to Adj. EBITDA1 ▪ Quarterly CFO benefited from lower WC investment 1.6x & higher profitability ▪ Healthy YTD FCF generation of $1
Slide 7: Summary
Summary ▪ Record Order Bookings and healthy Order Backlog ▪ Continued focus on margin expansion and deployment of ABM ▪ Sequential improvement in Services driven by regional support networks and digital offerings ▪ CFT voluntary tender offer process started on Dec 7 – platform acquisition in Food &
Slide 8: Appendix: Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures Notice to reader: Non-IFRS measures and additional IFRS measures Throughout this presentation management uses certain non-IFRS measures to evaluate the performance of the Company. The terms “operating margin”, “EBITDA”, “adjusted net inc